viloxazine has been researched along with Schizophrenia in 5 studies
Viloxazine: A morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Early-onset schizophrenia is notorious for poor prognostication and treatment-refractoriness." | 5.72 | Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains. ( Alamiri, B; Naguy, A; Pridmore, S; Rushdy, R; Singh, A, 2022) |
| "Our results provide tentative very low quality evidence that compared to placebo, NRIs (specifically reboxetine) may have a benefit on the negative symptoms of schizophrenia." | 4.98 | Selective noradrenaline reuptake inhibitors for schizophrenia. ( Horder, J; Matthews, PRL; Pearce, M, 2018) |
| " There appeared to be no difference between the viloxazine-treated group and the placebo-treated group, although the study raised some question as to the adequacies of the dosage utilized since there was an absence of any apparent side effects." | 2.65 | Viloxazine and the depressed schizophrenic--methodological issues. ( Kurland, AA; Nagaraju, A, 1981) |
| "Early-onset schizophrenia is notorious for poor prognostication and treatment-refractoriness." | 1.72 | Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains. ( Alamiri, B; Naguy, A; Pridmore, S; Rushdy, R; Singh, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naguy, A | 1 |
| Rushdy, R | 1 |
| Pridmore, S | 1 |
| Singh, A | 1 |
| Alamiri, B | 1 |
| Matthews, PRL | 1 |
| Horder, J | 1 |
| Pearce, M | 1 |
| Kurland, AA | 1 |
| Nagaraju, A | 1 |
| Guliamov, MG | 1 |
| Kornhuber, HH | 1 |
| Lisson, G | 1 |
| Rissotto, R | 1 |
1 review available for viloxazine and Schizophrenia
| Article | Year |
|---|---|
Selective noradrenaline reuptake inhibitors for schizophrenia.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Citalopram; Cognition; Humans; Morph | 2018 |
2 trials available for viloxazine and Schizophrenia
| Article | Year |
|---|---|
Viloxazine and the depressed schizophrenic--methodological issues.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Depression; Double-Blind Method; Drug Therapy, Comb | 1981 |
[Treatment of schizophrenia without symptoms with viloxazine].
Topics: Clinical Trials as Topic; Depression; Humans; Morpholines; Schizophrenia; Viloxazine | 1985 |
2 other studies available for viloxazine and Schizophrenia
| Article | Year |
|---|---|
Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains.
Topics: Adolescent; Antipsychotic Agents; Clozapine; Cognition; Humans; Schizophrenia; Viloxazine | 2022 |
[Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit].
Topics: Adjustment Disorders; Adolescent; Adult; Aminoquinolines; Antidepressive Agents; Bipolar Disorder; D | 1986 |